21
Total investments
10
Early stage
3
Mid stage
0
Late stage
5y
Years active
Portfolio
21 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
2026
Were a full-stack Physical AI company building and deploying general-purpose robots that put human ingenuity to work at industrial scale. Our robots continuously learn and improve while performing real work, today. And we are working toward a future where AI and robotics expand human potential and improve quality of life for everyone.
Founded in 2026 by pioneers in robotics and AI from Toyota Research Institute, MIT, Stanford, and Amazon, Walden combines Large Behavior Models with real-world operation and its own expert teams to bring capable robots to industry today.
Investor
2026
At SiPhox Health, our mission is to tackle the problem of chronic diseases by enabling new Direct-to-Consumer health and wellness solutions. With six out of ten Americans living with chronic conditions, we’re dedicated to revolutionizing health diagnostics with next-generation infrastructure for home use.
SiPhox was founded by MIT scientists Michael Dubrovsky and Diedrik Vermeulen to integrate microfluidics and biochemistry with Silicon Photonics to miniaturize protein and hormone testing. As we work on building advanced home diagnostic devices, we are creating the most comprehensive at-home test kit on the market, providing valuable health insights and actionable plans to help achieve health goals.
The entire SiPhox team is driven by a shared passion: combating the chronic disease epidemic. We envision a future where staying healthy is not only affordable and convenient but also enjoyable for everyone. This mission is deeply personal to us – its about our own well-being, the health of our families, and the prosperity of humanity as a whole.
Investor
2025
Generation Lab aims to extend the human healthspan with the first test based on clinically relevant biological evidence that measures individuals’ biological age progression and risk of disease so everyone can live longer, healthier lives. Co-founded by a preeminent aging and longevity researcher from UC Berkeley, Generation Lab combines a simple cheek-swab test with proprietary techniques to definitively measure molecular disbalance that indicates aging and risk of disease. The company works with clinicians who can recommend personalized interventions, and Generation Lab can measure the effectiveness of these over time. Join the waitlist at generationlab.co.
Investor
2025
Nucleus is an advanced DNA health test that takes the guesswork out of healthcare, whether it’s knowing your risk for cancer or planning for a healthy family.
Genomic testing has always been fragmented— there are over 70,000 genetic tests on the market today, each analyzing different genes or markers. Our technology combines all these tests into one to analyze your risk for over 800 conditions with a single swab.
Knowledge is power. We deliver the insights you need to take action and live healthier, longer.
Investor
2025
Welcome to Classiq - Leading Quantum Computing Software
Inspired by traditional semiconductor design automation, Classiq combines deep quantum expertise with novel implementation of classical computing software automation.
This combination of deep technologies is designed to transform the quantum software stack, today and in the future. With an IDE, SDK, Compiler and OS for quantum computing, Classiq is positioned at the intersection of quantum physics and computer science. Classiq’s transformative offering is being woven into the fabric of the quantum computing ecosystem:
QUANTUM DEVELOPERS:
As quantum computers get more powerful gate-level manual coding becomes impractical, and at times impossible. Classiq’s unique technology changes that. Classiq’s high-level quantum development environment offers functional libraries and deploys advanced heuristics and algorithms to synthesize quantum circuits automatically. Experts and beginners alike are now able to implement advanced scalable quantum circuits that are automatically optimized for a specific quantum machine, as well as easy benchmarking. Execution on quantum machines and simulators is built-in.
QUANTUM COMPUTER PROVIDERS:
Classiq’s software can be deployed as a dedicated front-end operating system offering customers best-in-class features maximizing customer insights and productivity.
QUANTUM CLOUDS:
Classiq’s hardware agnostic development software enables programs in all leading quantum programming languages providing broad access to and driving adoption of cloud platforms.
HPC & ADVANCED COMPUTATION:
Classiq’s scalable automation and classical computing underpinning make it a natural partner for today’s supercomputing providers seeking to integrate seamlessly with quantum computing. Classiq is collaborating with the world’s leading supercomputing providers to build seamless architectures to combine the best of both classical and quantum computing.
Investor
2025
Higgsfield is the ultimate production studio for creators by creators.
40% of our team are filmmakers, producers, and creatives who shape our product roadmap, working side by side with our ML engineers in a relentless creative feedback loop.
Were on a mission to give everyone with a vision the tools of a world-class studio. Higgsfield is where your ideas become cinema.
Board Observer
2024
Unbabel eliminates language barriers so that businesses can thrive across cultures and geographies.
The company’s language operations platform blends advanced artificial intelligence with human editors, for fast, efficient, high-quality translations that get smarter over time. Unbabel integrates seamlessly in any channel, so agents can deliver consistent multilingual support from within their existing workflows. Making it easy for enterprises to grow into new markets and build customer trust in every corner of the world.
Based in San Francisco, Calif., Unbabel works with leading customer support teams at brands such as Microsoft, Booking.com, Udemy, and Panasonic, to communicate effortlessly with customers around the world, no matter what language they speak.
Investor
2024
At Normal, were rewriting AI foundations to advance the frontier of reasoning and reliability in the physical world. We are tackling problems across semiconductors and industrials with a mix of interdisciplinary approaches across the full stack: from probabilistic software infrastructure and algorithms to hardware and physics, enabling AI that can reason and understand its own limits.
We understand that our technology is only as powerful as the people behind it. Every employee drives significant impact within our products, often working directly with customers and embedding across our tightly-knit team. Our team members are driven by curiosity and passion for solving some of the most challenging problems in the world of atoms.
Normal was founded in 2022 by engineers and scientists that pioneered industry-leading Physics + ML tools for next-gen AI at Google Brain and Google X.
Investor
2024
Ceramic.ai builds enterprise-grade infrastructure to optimize how companies train and deploy their AI models faster and more efficiently.
Investor
2024
Synthefy is building multi-modal generative AI models for time series data. We enable you to search, forecast, and synthesize privacy-preserving time series data – all from a simple text prompt!
Investor
2024
Leading edge research, proprietary models and agents, and a forward-deployed implementation approach for tangible ROI
Investor (acquired by Canva)
2023
We’re building an entire generative content production platform that incorporates numerous forms of Generative Ai. Supercharge your asset production with our tooling and workflows.
Investor
2023
Inworld AI is a realtime AI model and infrastructure company, and the leading consumer AI infrastructure platform. Inworld provides industry-leading realtime generative models, including the world’s #1-ranked voice AI models, intelligent model routing and optimization, and an Agent Runtime, enabling developers to build and deploy interactive AI applications to millions of concurrent users.
Inworld primarily serves use cases where realtime interaction and sophisticated agent capabilities are critical, such as companion apps, developer assistants, and agents for learning & education, health & wellness, interactive media and enterprise.
At its core, Inworld is a product-oriented research lab of top AI researchers and engineers. The founding team led product for LLMs at DeepMind and built Dialogflow, the conversational AI platform acquired by Google. Inworld has raised $125M+ from Lightspeed, Kleiner Perkins, Founders Fund, CRV, Stanford, Microsoft M12, Meta, Intel Capital, Samsung NEXT, LG Tech Ventures, and Bitkraft among others.
Show all 21 investments ↓
Experience · 22 entries
All (22)
Investments (21)
Board (1)
2026
Investor
2026
Were a full-stack Physical AI company building and deploying general-purpose robots that put human ingenuity to work at industrial scale. Our robots continuously learn and improve while performing real work, today. And we are working toward a future where AI and robotics expand human potential and improve quality of life for everyone.
Founded in 2026 by pioneers in robotics and AI from Toyota Research Institute, MIT, Stanford, and Amazon, Walden combines Large Behavior Models with real-world operation and its own expert teams to bring capable robots to industry today.
Investor
2026
At SiPhox Health, our mission is to tackle the problem of chronic diseases by enabling new Direct-to-Consumer health and wellness solutions. With six out of ten Americans living with chronic conditions, we’re dedicated to revolutionizing health diagnostics with next-generation infrastructure for home use.
SiPhox was founded by MIT scientists Michael Dubrovsky and Diedrik Vermeulen to integrate microfluidics and biochemistry with Silicon Photonics to miniaturize protein and hormone testing. As we work on building advanced home diagnostic devices, we are creating the most comprehensive at-home test kit on the market, providing valuable health insights and actionable plans to help achieve health goals.
The entire SiPhox team is driven by a shared passion: combating the chronic disease epidemic. We envision a future where staying healthy is not only affordable and convenient but also enjoyable for everyone. This mission is deeply personal to us – its about our own well-being, the health of our families, and the prosperity of humanity as a whole.
2025
Investor
2025
Generation Lab aims to extend the human healthspan with the first test based on clinically relevant biological evidence that measures individuals’ biological age progression and risk of disease so everyone can live longer, healthier lives. Co-founded by a preeminent aging and longevity researcher from UC Berkeley, Generation Lab combines a simple cheek-swab test with proprietary techniques to definitively measure molecular disbalance that indicates aging and risk of disease. The company works with clinicians who can recommend personalized interventions, and Generation Lab can measure the effectiveness of these over time. Join the waitlist at generationlab.co.
Show all 22 entries ↓
Investment activity
2021–2026 · 21 investments
Recent (last 2 years)Earlier
